Cargando…

Know your limits: RPA availability and chemoresistance in ovarian cancer

Detalles Bibliográficos
Autores principales:	Fortier, Emile, Drobetsky, Elliot, Wurtele, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368229/ https://www.ncbi.nlm.nih.gov/pubmed/30783508 http://dx.doi.org/10.18632/oncotarget.26607

Ejemplares similares

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Grammar: know your shit or know you're shit
por: Adams, Joanne
Publicado: (2015)

Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies: identification of RPA1 as a novel cancer predisposition candidate gene
por: Sharma, Richa, et al.
Publicado: (2023)

Cancer chemoresistance and BAK
por: Fox, Joanna L.
Publicado: (2015)

Fighting sudden cardiac death in India – Knowing your enemy is half the battle
por: Selvaraj, Raja
Publicado: (2016)

Your Unconscious Knows Your Name
por: Pfister, Roland, et al.
Publicado: (2012)

Host–Parasite Relationships in Veterinary Parasitology: Get to Know Your Enemy before Fighting It
por: González-Miguel, Javier
Publicado: (2022)

Cancer therapy: know your enemy?
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014)

Worth Your Knowing
Publicado: (1895)

Know Your Epidemic, Strengthen Your Response: Developing a New HIV Surveillance Architecture to Guide HIV Resource Allocation and Target Decisions
por: Rice, Brian, et al.
Publicado: (2018)

Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
por: Liu, Guo-Yan, et al.
Publicado: (2012)

Upper limbs: how physically limited is your patient?
por: Furlanetto, Karina Couto, et al.
Publicado: (2020)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Know your dose: RADDOSE
por: Paithankar, Karthik S., et al.
Publicado: (2010)

Know your yellow lesions!
por: Arthi, M., et al.
Publicado: (2023)

Know Your Shoppers (Collection)
por: Sorensen, Herb
Publicado: (2013)

A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21
por: Bélanger, François, et al.
Publicado: (2023)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Obesity: an heavyweight player in breast cancer’s chemoresistance
por: Vaysse, Charlotte, et al.
Publicado: (2019)

Know can do!: put your know-how into action
por: Blanchard, Kenneth H, et al.
Publicado: (2007)

You know the Science. Do you know your Code?
por: Baxter, Ira
Publicado: (2014)

Controlling secretion to limit chemoresistance
por: Georgilis, Athena, et al.
Publicado: (2016)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

HARP preferentially co-purifies with RPA bound to DNA-PK and blocks RPA phosphorylation
por: Quan, Jinhua, et al.
Publicado: (2014)

Wants to Know You Know
Publicado: (1885)

Dynamics and Selective Remodeling of the DNA Binding Domains of RPA
por: Pokhrel, Nilisha, et al.
Publicado: (2019)

Opto-magnetic capture of individual cells based on visual phenotypes
por: Binan, Loïc, et al.
Publicado: (2019)

Renormalized RPA at finite temperature
por: Avdeenkov, A V, et al.
Publicado: (1995)

Know Your Client and Know Your Team: A Complexity Inspired Approach to Understanding Safe Transitions in Care
por: Tregunno, Deborah
Publicado: (2013)

“Know your epidemic, know your response”: Epidemiological assessment of the substance use disorder crisis in the United States
por: Hernández, Andrés, et al.
Publicado: (2021)

To know the objective is not (necessarily) to know the objective function
por: Sipper, Moshe, et al.
Publicado: (2018)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

Know your epidemic, know your response: understanding and responding to the heterogeneity of the COVID‐19 epidemics across Southeast Asia
por: Sohn, Annette H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_19n8du4akvthu9lh7tuis3fugj